SUMMARY -Chorea may occur as a neurological manifestation of systemic lupus erythematosus and is often associated with detection of antiphospholipid antibodies. No evidence of chorea as a sign of lupus activity has been established. W e describe a patient with systemic lupus erythematosus associated with antiphospholipid antibodies who developed chorea, which has been considered a sign of lupus activity.
Chorea is a rare but well recognized neurological manifestation of systemic lupus erythematosus (SLE). It occurs in less than 2% of patients with SLE and can be the first evidence of the disease i.^. Previous reports emphasized the relationship between chorea in SLE and antiphospholipid antibodies, but the pathogenesis of this association is still poorly understood 1 7 . These antibodies might be related to direct damage to the basal ganglia 1 . Evidence lacks that could establish a close relationship between chorea and SLE activity.
We describe the case of a patient with SLE in whom chorea was an early manifestation of the disease and has been considered a probable sign of SLE activity.
CASE REPORT
LALi, a 15 year old white female was admitted to our Hospital with a history ot personality changes and memory impairment in the last four years. Episodes of polyarthralgia were also mentioned. Six months after the onset of symptoms involuntary (choreic) movements appeared first affecting her right hand, and after a few months involving the four limbs, mouth and tongue. This clinical picture progressed slowly, with deterioration of cognitive Immunosuppresive therapy with prednisone (60mg daily) and azathioprine (150mg daily) was started. Propranolol (80mg a day) was also prescribed for hypertension. A good clinical response was obtained with complete control of the chorea even after discontinuation of haloperidol. At discharge she was receiving prednisone, azathioprine, propranolol and phéno barbital (lOOmg a diay). After a ten-month follow-up period at the Outpatient Unit the pa tient remained clinically stable. An attempt to reduce the immunosuppressive dosages resulted in relapse of symptoms (choreic movements). Laboratory investigation yielded no sign ot systemic activity. However, restoration of previous doses of the same immunosuppressive agents permitted again control of chorea.
COMMENTS
The association between, chorea and SLE is well established as has been pointed out by several reports 1.4,6,7,9. Unfortunately, the pathogenesis of this occurrence is still unknown. Neuropathological investigations failed to demons trate lesions in brain areas which may be related to the clinical picture of chorea 9. Nevertheless, owing both to the thrombotic tendency of these patients 1 . This association suggests that these antibodies could cause direct damage to the basal ganglia by binding phospholipid structures in this region 1 . A possible mechanism that has been postulated is that these antibodies might bind phospholipids in the endothelial cell membrane resulting in blockade of arachidonic acid release and reduction in prostacyclin production, thus increasing platelet aggregation and thrombosis 5 .
However, a recent report suggests that the occurrence of antiphospholipid antibodies in immune diseases of the nervous system could be just an immune epiphenomenon. Marchiori et al. studied 81 patients with multiple sclerosis, Guillain-Barré syndrome and SLE detecting significant levels of antiphospholipid antibodies (specially anticardiolipin) in many of them 1 *).
Our patient has major neurological manifestations associated with SLE, namely chorea, dementia and seizures. It could be assumed that it is a predomi nantly cerebral form of the disease. The presence of antiphospholipid antibodies confirms the tendency of their detection in SLE cases with chorea.
No close relationship between SLE activity and chorea has been established. The laboratory data of our case do not show evidence of systemic activity of the disease, but based on the criteria of lupus activity described by Urowitz et al. the disease should be considered as active 1 1 . Furthermore, both the good response obtained with immunosuppressive treatment and the recurrence of symptoms with dose reduction point to a possible liaison between chorea and SLE activity. In our opinion, although observed in an isolated case, chorea may be considered to occur not only as a manifestation of SLE but also as a sign of SLE activity.
